Paradigm Biocapital Advisors LP Compass Pathways PLC Transaction History
Paradigm Biocapital Advisors LP
- $2.77 Billion
- Q3 2024
A detailed history of Paradigm Biocapital Advisors LP transactions in Compass Pathways PLC stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 1,160,000 shares of CMPS stock, worth $9.91 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
1,160,000
Previous 2,335,926
50.34%
Holding current value
$9.91 Million
Previous $19.9 Million
50.34%
% of portfolio
0.36%
Previous 0.81%
Shares
5 transactions
Others Institutions Holding CMPS
# of Institutions
151Shares Held
33.6MCall Options Held
536KPut Options Held
582K-
Ken Griffin Citadel Advisors LLC | Chicago, Il5.41MShares$46.2 Million0.01% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA3.86MShares$32.9 Million4.27% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.76MShares$32.1 Million0.02% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl2.01MShares$17.1 Million0.16% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.61MShares$13.7 Million2.01% of portfolio
About COMPASS Pathways plc
- Ticker CMPS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Care Facilities
- Shares Outstandng 42,522,400
- Market Cap $363M
- Description
- COMPASS Pathways plc operates as a mental health care company primarily in the United Kingdom and the United States. It develops COMP360, a psilocybin therapy that has completed Phase IIb clinical trials for the treatment of treatment-resistant depression; and is in Phase II clinical trials for the treatment of post-traumatic stress disorder. Th...